1. ScholarBank@NUS

Pei Yong Shi

rp19658

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Pei Yong Shi
Main Affiliation
 
Faculty
 
Email
gmsspy@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Subject:  human

Results 1-11 of 11 (Search time: 0.023 seconds).

Issue DateTitleAuthor(s)
12018An evolutionary NS1 mutation enhances Zika virus evasion of host interferon inductionXia, H; Luo, H; Shan, C; Muruato, A.E; Nunes, B.T.D; Medeiros, D.B.A; Zou, J; Xie, X; Giraldo, M.I; Vasconcelos, P.F.C; Weaver, S.C; Wang, T; Rajsbaum, R; Shi, P.-Y 
22018Characterization of a candidate tetravalent vaccine based on 2’-O-methyltransferase mutantsZüst R.; Li S.-H.; Xie X.; Velumani S.; Chng M.; Toh Y.-X.; Zou J.; Dong H.; Shan C.; Pang J.; Qin C.-F.; Newell E.W.; Shi P.-Y. ; Fink K.
32017Dengue subgenomic flaviviral RNA disrupts immunity in mosquito salivary glands to increase virus transmissionPompon J. ; Manuel M.; Ng G.K.; Wong B.; Shan C.; Manokaran G.; Soto-Acosta R.; Bradrick S.S.; Ooi E.E. ; Missé D.; Shi P.-Y. ; Garcia-Blanco M.A.
42014Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future DirectionsWhitehorn J.; Yacoub S.; Anders K.L.; Macareo L.R.; Cassetti M.C.; Nguyen Van V.C.; Shi P.-Y. ; Wills B.; Simmons C.P.
52018Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backboneLi, X.-F; Dong, H.-L; Wang, H.-J; Huang, X.-Y; Qiu, Y.-F; Ji, X; Ye, Q; Li, C; Liu, Y; Deng, Y.-Q; Jiang, T; Cheng, G; Zhang, F.-C; Davidson, A.D; Song, Y.-J; Shi, P.-Y ; Qin, C.-F
62017Evaluation of a novel reporter virus neutralization test for serological diagnosis of Zika and Dengue virus infectionShan, C; Ortiz, D.A; Yang, Y; Wong, S.J; Kramer, L.D; Shi, P.-Y ; Loeffelholz, M.J; Ren, P
72015Flexibility of NS5 methyltransferase-polymerase linker region is essential for dengue virus replicationZhao Y.; Soh T.S.; Chan K.W.K. ; Fung S.S.Y. ; Swaminathan K. ; Lim S.P. ; Shi P.-Y. ; Huber T.; Lescar J. ; Luo D.; Vasudevan S.G. 
82016Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance ProfilingLim S.P. ; Noble C.G.; Seh C.C.; Soh T.S.; El Sahili A.; Chan G.K.Y. ; Lescar J.; Arora R.; Benson T.; Nilar S.; Manjunatha U. ; Wan K.F.; Dong H.; Xie X.; Shi P.-Y. ; Yokokawa F.
92013Rational Design of a Live Attenuated Dengue Vaccine: 2?-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and MacaquesZüst R.; Dong H.; Li X.-F.; Chang D.C.; Zhang B.; Balakrishnan T.; Toh Y.-X.; Jiang T.; Li S.-H.; Deng Y.-Q.; Ellis B.R.; Ellis E.M.; Poidinger M. ; Zolezzi F.; Qin C.-F.; Shi P.-Y. ; Fink K.
102012Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical TrialsSimmons C.P.; Wolbers M.; Nguyen M.N.; Whitehorn J.; Shi P.Y. ; Young P.; Petric R.; Nguyen V.V.C.; Farrar J.; Wills B.
112013West Nile virus drug discoveryLim, S.P ; Shi, P.-Y